Averozolid
Linezolid 200 mg/100ml solution in vial for I.V. Infusion
Averozolid is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Averozolid is not indicated for the treatment of Gram negative infections. It is critical that specific Gram-negative therapy be initiated immediately if a concomitant Gram-negative pathogen is documented or suspected.
|
Infection* |
Dosage , Route and Frequency of Administration |
Recommended Duration of Treatment ( consecutive days) |
|
| Pediatric Patients ( Birth through 11 Years of Age ) | Adults and Adolescents ( 12 Years and Older ) | ||
| Nosocomial pneumonia |
10 mg / kg intravenously every 8 hours |
600 mg intravenously every 12 hours |
10 to 14
|
| Community acquired pneumonia , including concurrent bacteremia | |||
| Complicated skin and skin structure infections | |||
| Vancomycin resistant Enterococcus faecium infections , including concurrent bacteremia | 10 mg / kg intravenously every 8 hours | 600 mg intravenously every 12 hours |
14 to 28 |
